Gramics Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
5
Gramics Bio General Information
Description
Developer of non-viral gene therapy technology designed to enable durable and cell-type-specific deoxyribonucleic acid delivery for genetic medicine. The company engineers synthetic deoxyribonucleic acid sequences, integrates artificial intelligence with high-throughput screening, and supports programmable gene delivery using lipid nanoparticle systems, enabling biotechnology and pharmaceutical companies to develop durable and repeatable gene therapies.
Contact Information
Website
www.gramicsbio.comCorporate Office
- First Floor
- 85 Great Portland Street
- London W1W 7LT
- England, United Kingdom
Corporate Office
- First Floor
- 85 Great Portland Street
- London W1W 7LT
- England, United Kingdom
Gramics Bio Timeline
Gramics Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A) | Cancelled | Generating Revenue | ||||
| 5. Seed Round | Cancelled | Generating Revenue | ||||
| 4. Accelerator/Incubator | 19-Sep-2024 | Completed | Generating Revenue | |||
| 3. Seed Round | 19-Jun-2024 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-May-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Gramics Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Gramics Bio Signals
Gramics Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Science Entrepreneur Club | Accelerator/Incubator | |||
| Cystic Fibrosis Foundation | Limited Partner | Minority | ||
| Deep Science Ventures | Venture Capital | Minority | ||
| Stevenage Bioscience Catalyst | Accelerator/Incubator | |||
| The Francis Crick Institute | Accelerator/Incubator |
Gramics Bio FAQs
-
When was Gramics Bio founded?
Gramics Bio was founded in 2024.
-
Where is Gramics Bio headquartered?
Gramics Bio is headquartered in London, United Kingdom.
-
What is the size of Gramics Bio?
Gramics Bio has 3 total employees.
-
What industry is Gramics Bio in?
Gramics Bio’s primary industry is Biotechnology.
-
Is Gramics Bio a private or public company?
Gramics Bio is a Private company.
-
What is Gramics Bio’s current revenue?
The current revenue for Gramics Bio is .
-
How much funding has Gramics Bio raised over time?
Gramics Bio has raised $318K.
-
Who are Gramics Bio’s investors?
Science Entrepreneur Club, Cystic Fibrosis Foundation, Deep Science Ventures, Stevenage Bioscience Catalyst, and The Francis Crick Institute have invested in Gramics Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process